Report

Fresenius SE & CO KGaA : CMD feedback: Combining the best of German and Spanish hospitals

>Best practice transfer between Germany and Spain - At its CMD on 7-8 June Fresenius SE provided a deep dive into its Helios business. The presentation was mostly qualitative and focused on: i/ a comparison of Helios Germany and Quironsalud (Spanish hospital operator acquired in 2016); ii/ an overview of the Spanish and German hospital markets, and iii/ strategy by country. The annual synergy potential of € 50m comprises € 30m cost synergies and € 20m sales synergies...
Underlying
Fresenius SE & Co. KGaA

Fresenius is a health care group providing products and services for dialysis, hospitals and outpatient medical care. Co. operates four business segments: Fresenius Medical Care; Fresenius Kabi; Fresenius Helios; and Fresenius Vamed. Fresenius Medical Care provides dialysis care and dialysis products for patients with chronic kidney failure. Fresenius Kabi is engaged in the provision of generic drugs, infusion therapies, clinical nutrition products, related medical devices and transfusion technology. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. Fresenius Helios is a private hospital operator which only operates in Germany.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch